Bacterial biofilm in the oral cavity and around dental implants may trigger an inflammatory response of the peri-implant soft tissue. Emerging antimicrobial products have been developed to combat peri-implant soft tissue pathology; however, limited evidence is available evaluating their effectiveness. To the best of the authors’ knowledge, this is the first documented case report in the literature assessing the effect of Cervitec Plus around dental implants. This case report provides an example of a patient presenting to a periodontal specialty clinic with peri-implant pathology and subsequently treated with antimicrobial varnish following dental hygiene peri-implant therapy. The report serves to evaluate the efficacy of peri-implant soft tissue pathology utilizing antimicrobial varnish as measured by percent of bleeding upon probing, presence of suppuration, and changes in implant probing depths. Understanding the impact of bacterial plaque on peri-implant soft tissue and the effectiveness of antimicrobial products in conjunction with dental hygiene peri-implant therapy may provide patients with optimal peri-implant health and long-term success of dental implants.